Dealing with Rare and Orphan Diseases:The Technology Imperative
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
Dealing with Rare and Orphan Diseases:The Technology Imperative
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode of Future of Humanity, we will be talking about Rare Diseases with Dr. Vijay Chandru, the Founder and Executive-Chairman of Strand Life Sciences based in Bangalore, India.
The fact is that very few people, mostly children, get these diseases due primarily to random faulty genes. Given that the market size is small, pharmaceutical companies do not always focus on finding a cure; hence they are sometimes called "orphan" diseases. Even when one finds a cure, the cost to the patients and their families could be prohibitive.
Professor Chandru and I will be talking about the different technological interventions that are being pursued across the world to deal with this difficult health issue, and the prognosis for success.
Pas encore de commentaire